首页> 外文期刊>Innovations: technology and techniques in cardiothoracic and vascular surgery >Outcomes of Aortic Valve and Concomitant Ascending Aorta Replacement Performed via a Minimally Invasive Right Thoracotomy Approach
【24h】

Outcomes of Aortic Valve and Concomitant Ascending Aorta Replacement Performed via a Minimally Invasive Right Thoracotomy Approach

机译:主动脉瓣和伴随升主动脉置换的结果通过微创右胸腔切开术进行

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: Replacement of the aortic valve with concomitant replacement of the ascending aorta performed via a minimally invasive right anterior thoracotomy approach has not been reported. We evaluated the feasibility and safety of this procedure. Methods: We retrospectively reviewed all minimally invasive aortic valve replacements (AVRs) with concomitantreplacement of the ascending aorta performed at our institution between January 1, 2012, and December 30, 2012. The operative times, intensive care unit and hospital lengths of stay, postoperative outcomes, as well as mortality were analyzed. Results: A total of 20 consecutive patients who underwent minimally invasive AVR with concomitant replacement of the ascending aorta were identified. There were 16 men (80%), with a mean (SD) age of 61 (13) years. The mean (SD) left ventricular ejection fraction was 58% (8%). The aortic valve was bicuspid in 18 patients (80%), with 14 (70%) being stenotic. The median aortic cross-clamp and cardiopulmonary bypass times were 163 [interquartile range (IQR), 141-170] minutes and 291 (IQR, 177-215) minutes, respectively. Hypothermic circulatory arrest was required in 19 patients (95%), with a median hypothermic circulatory arrest time of 35 (IQR, 33-39.5) minutes. The median intensive care unit and hospital lengths of stay were 24 (IQR, 23-41) hours and 5 (IQR, 4-6) days, respectively. There were no strokes, reoperations for bleeding, or conversions to sternotomy. The 30-day mortality was zero. Conclusions: Minimally invasive AVR with concomitant replacement of the ascending aorta, via a right anterior thoracotomy approach, can be performed with low morbidity and mortality.
机译:目的:尚未报道通过微创右前胸廓切开术同时进行升主动脉置换的主动脉瓣置换术。我们评估了该程序的可行性和安全性。方法:我们回顾性研究了2012年1月1日至2012年12月30日在我院进行的所有微创主动脉瓣置换术(AVR)并伴有升主动脉的置换。手术时间,重症监护病房和住院时间,术后时间结果和死亡率进行了分析。结果:总共鉴定出20例接受微创AVR并伴有升主动脉置换的患者。有16名男性(80%),平均(SD)年龄为61(13)岁。左室射血分数的平均值(SD)为58%(8%)。 18例(80%)患者的主动脉瓣是双尖瓣,其中14例(70%)为主动脉瓣狭窄。中位主动脉交叉钳夹和体外循环时间分别为163 [四分位间距(IQR),141-170]分钟和291 [IQR,177-215)分钟。 19例患者(95%)需要进行低温循环停止,平均低温循环停止时间为35分钟(IQR,33-39.5分钟)。重症监护病房和医院的中位住院时间分别为24(IQR,23-41)小时和5(IQR,4-6)天。没有中风,没有因出血而再次手术,也没有转换为胸骨切开术。 30天死亡率为零。结论:通过右前胸廓切开术同时进行升主动脉置换的微创AVR可以降低发病率和死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号